Revance Therapeutics Inc RVNC Valuation Ratios and Share Stats

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Revance Therapeutics Inc (RVNC)
Revance Therapeutics Inc (RVNC) Financials

Revance Therapeutics Inc (RVNC)

3.92

0.16

(4.26%)

At close: July 26 4:00PM

Delayed by 15 minutes

4.00

0.08

( 2.04% )

After Hours: 6:55PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Return on Assets (%)	-37.182	-48.229	-54.619	-56.272	-53.199	-44.96	-64.043	-61.109
Return on Equity (%)	-41.49	-54.085	-68.796	-85.92	-94.064	-127.071	-879.284	466.153
Return on Invested Capital (%)	-36.451	-52.752	-71.169	-90.18	-68.415	-58.886	-71.466	-76.956
Operating Margin (%)	-29396	-45851.145	-3741.593	-38602.663	-1758.962	-353.527	-255.911	-130.033
Net Profit Margin (%)	-29756.667	-46025.573	-3823.223	-38602.663	-1840.711	-361.59	-268.866	-138.432
Book Value Per Share	6.26	7.362	3.938	4.305	2.255	-1.87	-1.112	-1.838
Earnings Per Share	-3.156	-3.302	-3.856	-3.044	-4.078	-3.93	-4.326	-3.689
Cash Per Share	2.245	7.747	1.981	3.255	4.822	1.545	1.323	1.564
Working Capital Per Share	6.117	7.238	4.759	4.881	5.624	2.498	3.63	2.843
Operating Profit Per Share	0.011	0.007	0.101	0.008	0.153	0.76	0.982	1.818
EBIT Per Share	-3.156	-3.302	-3.775	-3.044	-4.116	-3.93	-4.318	-3.686
EBITDA Per Share	-3.156	-3.302	-3.775	-3.044	-4.116	-3.93	-4.318	-3.686
Free Cash Flow Per Share	-3.148	-3.274	-3.713	-3.038	-4.165	-4.062	-4.697	-3.767

Liquidity Ratios

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	9.808	13.645	6.504	7.238	7.381	3.658	4.951	3.798
Quick Ratio	9.447	13.537	6.344	7.08	7.19	3.395	4.652	3.162
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	139.95	47.639	50.455	71.083
Shares Outstanding	28.29M	36.52M	36.98M	52.38M	69.18M	71.58M	82.39M	N/A

Key Stats and Ratios

Year End December 30 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Shares Outstanding	73.12M	82.29M	82.39M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-112.092	N/A	N/A	N/A	-85.238
Net Profit Margin (%)	N/A	N/A	N/A	-121.208	N/A	N/A	N/A	-102.341
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	4.142	N/A	N/A	N/A	5.365
Quick Ratio	N/A	N/A	N/A	3.713	N/A	N/A	N/A	4.463
Inventory Turnover (Days)	N/A	N/A	N/A	205.507	N/A	N/A	N/A	353.362

Key Stats and Ratios

Market Cap	392.73M
Price to Earnings Ratio	-1.26
Price to Sales Ratio	1.75
Price to Cash Ratio	2.98
Price to Book Ratio	-2.7
Dividend Yield	-

Share Statistics

Shares Outstanding	104.45M
Average Volume (1 week)	1.87M
Average Volume (1 Month)	1.87M
52 Week Change	-82.32%
52 Week High	24.87
52 Week Low	2.30

More Ratios Coming Soon!

Revance Therapeutics

Delayed Upgrade Clock